Adherence quietly decides type 2 diabetes outcomes, and it happens where most healthcare software isn’t — the between-visit gap. A structured self-management program on infrastructure the clin...
A cross-sectional study measured AI-generated type 2 diabetes information on quality, readability, and transparency — and found variance patients can’t detect. ‘The AI told me’ can...
A middleman at the heart of America’s insulin-pricing scandal just agreed to cap members’ insulin at $25 a month — and to change the rebate machinery beneath it. What the CVS Caremark se...
Zhang et al. (2026) discovered that α-eleostearic acid and its methyl ester act as novel senolytic agents by inducing ferroptosis in senescent cells, achieving over 80% clearance with minimal toxicit...
Recent research identifies specific senescent cell types linked to diabetes and hypertension, enabling personalized therapies and AI-driven predictive health tools for aging populations. New studies m...
Personalized nutrition leverages AI and genomic data to create tailored diets, improving metabolic health and reducing chronic diseases, as shown in recent studies and FDA approvals. AI-driven persona...
Advances in AI and genomics are tailoring diets to individual needs, improving metabolic health and reducing disease risks like obesity and diabetes through data-driven insights. Personalized nutritio...
Recent studies reveal specific gut bacteria strains like Faecalibacterium prausnitzii and Lactobacillus rhamnosus GG improve mental health and metabolic regulation, prompting calls for personalized pr...
New research reveals prenatal PFAS exposure disrupts maternal beta cell function, increasing diabetes risk, with significant socioeconomic disparities in exposure levels. Recent studies show prenatal ...
Recent studies highlight curcumin’s potential in managing diabetes and hypertension, with new formulations enhancing bioavailability and clinical efficacy. New research reveals curcumin’s ...